Literature DB >> 16873808

Suspected acute coronary syndrome patients with diabetes and normal troponin-I levels are at risk for early and late death: Identification of a new high-risk acute coronary syndrome population.

Steven P Marso1, David M Safley, John A House, Todd Tessendorf, Kimberly J Reid, John A Spertus.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16873808     DOI： 10.2337/dc06-0660

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  5 in total

Review 1.  Acute coronary syndrome in the patient with diabetes: is the management different?

Authors:  Amit P Amin; Steven P Marso
Journal:  Curr Cardiol Rep       Date:  2010-07       Impact factor: 2.931

Review 2.  Diabetes mellitus and acute coronary syndrome: lessons from randomized clinical trials.

Authors:  Sanjum S Sethi; Elias G Akl; Michael E Farkouh
Journal:  Curr Diab Rep       Date:  2012-06       Impact factor: 4.810

3.  Pregnancy-associated plasma protein-A is a stronger predictor for adverse cardiovascular outcomes after acute coronary syndrome in type-2 diabetes mellitus.

Authors:  Wei-Ping Li; Moni B Neradilek; Fu-Sheng Gu; Daniel A Isquith; Zhi-Jun Sun; Xing Wu; Hong-Wei Li; Xue-Qiao Zhao
Journal:  Cardiovasc Diabetol       Date:  2017-04-05       Impact factor: 9.951

4.  Detectable subclinical myocardial necrosis is associated with cardiovascular risk in stable patients with diabetes.

Authors:  W H Wilson Tang; Yuping Wu; Earl B Britt; Naveed Iqbal; Stanley L Hazen
Journal:  Diabetes Care       Date:  2013-02-07       Impact factor: 19.112

5.  The influence of smoking and impaired glucose homoeostasis on the outcome in patients presenting with an acute coronary syndrome: a cross-sectional study.

Authors:  Jacob Odeberg; Michael Freitag; Henrik Forssell; Ivar Vaara; Marie-Louise Persson; Håkan Odeberg; Anders Halling; Lennart Råstam; Ulf Lindblad
Journal:  BMJ Open       Date:  2014-07-03       Impact factor: 2.692
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.